PT G20210A, factors V G1691A and 1299 His-Arg mutations and tamoxifen-associated thromboembolism in patients with breast cancer

被引：7
|
作者：
Eroglu, A
Çam, R
Yildiz, Z
Akar, N
机构：
[1] Ankara Univ, Sch Med, Breast Surg Unit, Dept Gen Surg, Ankara, Turkey
[2] Ankara Univ, Sch Med, Dept Pediat Mol Genet, Ankara, Turkey
来源：
THROMBOSIS RESEARCH | 2003年 / 111卷 / 4-5期
关键词：
D O I：
10.1016/j.thromres.2003.09.011
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：317 / 319
页数：3
相关论文
共 50 条
  • [21] Factor V G1691A and prothrombin G20210A gene polymorphisms among Iranian patients with cerebral venous thrombosis
    Ashjazadeh, Nahid
    Poursadeghfard, Maryam
    Farjadian, Shirin
    [J]. NEUROLOGY ASIA, 2012, 17 (03) : 199 - 203
  • [22] Factor V gene G1691A, prothrombin gene G20210A and factor V gene A407OG mutations in patients with Behcet's disease
    Ates, A
    Düzgün, N
    Akar, N
    Ulu, A
    Aydintug, O
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 366 - 366
  • [23] Coexistence of factor V G1691A and factor II G20210A gene mutations in a thrombotic family is associated with recurrence and early onset of venous thrombosis
    Gemmati, D
    Serino, ML
    Moratelli, S
    Tognazzo, S
    Ongaro, A
    Scapoli, GL
    [J]. HAEMOSTASIS, 2001, 31 (02) : 99 - 105
  • [24] Factor V Leiden and PT G20210A mutations in cancer patients with and without thrombosis
    Eroglu, A.
    Ulu, A.
    Kurtman, C.
    Akar, N.
    [J]. EJC SUPPLEMENTS, 2005, 3 (02): : 70 - 71
  • [25] Prevalence of antiphospholipid antibodies, factor V G1691A (Leiden) and prothrombin G20210A mutations in early and late recurrent pregnancy loss
    Mtiraoui, N
    Borgi, L
    Hizem, S
    Nsiri, B
    Finan, RR
    Gris, JC
    Almawi, WY
    Mahjoub, T
    [J]. EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2005, 119 (02) : 164 - 170
  • [26] Association of factor XIII Val34Leu, factor V G1691A and Pt G20210A with pregnancy loss.
    Krause, M
    Zwinge, B
    Boehm, M
    Scharrer, I
    [J]. BLOOD, 2003, 102 (11) : 310A - 310A
  • [27] The G1691A Mutation of the Factor V Gene (Factor V Leiden) and the G20210A Mutation of the Prothrombin Gene as Risk Factors in Thrombotic Microangiopathies
    Sucker, Christoph
    Kurschat, Christine
    Hetzel, Gerd R.
    Grabensee, Bernd
    Maruhn-Debowski, Beate
    Loncar, Robert
    Ostojic, Ljerka
    Scharf, Ruediger E.
    Zotz, Rainer B.
    [J]. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2009, 15 (03) : 360 - 363
  • [28] Combined heterozygous and homozygous factor V G1691A and prothrombin G20210A mutations as predictors of venous thrombosis during pregnancy.
    Gerhardt, A
    Zotz, RB
    Struve, S
    Scharf, RE
    [J]. BLOOD, 2001, 98 (11) : 790A - 790A
  • [29] The Factor V G1691A, Factor V H1299R, prothrombin G20210A polymorphisms in children with family history of premature coronary artery disease
    Ciftdogan, Dilek Yilmaz
    Coskun, Senol
    Ulman, Cevval
    Tikiz, Hakan
    [J]. CORONARY ARTERY DISEASE, 2009, 20 (07) : 435 - 439
  • [30] Factor V G1691A (Leiden) and prothrombin G20210A gene mutation status, and thrombosis in patients with chronic myeloproliferative disorders
    Soyer, Nur
    Kucukarslan, Ali Sahin
    Sahin, Fahri
    Cekdemir, Demet
    Kosova, Buket
    Eroglu, Zuhal
    Tobu, Mahmut
    Tombuloglu, Murat
    Cagirgan, Seckin
    Donmez, Ayhan
    Vural, Filiz
    Saydam, Guray
    [J]. TURKISH JOURNAL OF HEMATOLOGY, 2011, 28 (04) : 306 - 311
12345